Lilly and NVIDIA to Build the Most Powerful AI Supercomputer for Drug Discovery
Eli Lilly and Company (NYSE: LLY) announced a groundbreaking collaboration with NVIDIA to build the most powerful supercomputer ever owned
Read moreEli Lilly and Company (NYSE: LLY) announced a groundbreaking collaboration with NVIDIA to build the most powerful supercomputer ever owned
Read moreIn a transformative move for the U.S. healthcare manufacturing sector, Roche unveiled plans to invest $50 billion in American pharmaceutical
Read moreAs we approach the midpoint of the 2020s, the pharmaceutical industry has undergone a radical digital transformation, driven by the
Read moreResearchers and scientists worldwide can now access Evo 2, a massive new foundation model that deciphers the genetic code across
Read moreAmerican multinational pharma company Incyte and AI-focused biotech Genesis Therapeutics have announced a strategic collaboration to leverage artificial intelligence for
Read morePresident Donald Trump’s announcement of the $500 billion Stargate initiative marks a transformative moment for the pharmaceutical sector and healthcare
Read moreInsitro, a leading AI-driven drug discovery and development company, has entered into three strategic agreements with Eli Lilly and Company
Read moreAI firm Generate:Biomedicines announced on Tuesday that it has secured a $1B+ collaboration with Novartis to advance AI-driven protein therapeutics.
Read moreGoogle DeepMind has introduced AlphaProteo, an advanced AI system designed to generate novel proteins that bind to specific molecular targets.
Read moreIn a forward-thinking move, Sanofi, Formation Bio, and OpenAI have joined forces to harness the power of artificial intelligence in
Read more